Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preladenant in Japanese Subjects with Moderate to Severe Parkinson's Disease
NCT01294800Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of preladenant in Parkinson's disease (PD), sponsored by Merck & Co.. Started Feb 2011; status: completed.
02
Drugs
preladenant
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01294800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01294800.